Our 2016–2020 mission, to save children’s lives and protect people’s health by increasing equitable use of vaccines in lower-income countries, is guided by four strategic goals

The current five-year strategy was approved by the Board in June 2014 – the full implementation of the strategy will see developing countries immunise 300 million children, saving 5–6 million lives in the long term. 

Coverage and equity are at the core of our current strategy. While we continue to support countries to introduce new vaccines, our focus is expanding to reach every child with these vaccines. With as many as 20 countries transitioning out of our financial support in this period, ensuring that programmes are sustainable in the long term is essential. 

Gavi's strategy is a roadmap designed to help us respond to changes in the vaccine landscape and set five-year milestones en route to fulfilling our mission. As the current strategy is coming to an end soon, the Gavi Board approved the fifth phase of our strategy (for 2021-25 period) in June 2019 with the vision to ‘leave no-one behind with immunisation’:

• Phase V (2021-2025)

• Phase IV (2016-2020) 

• Phase III (2011-15)  

• Phase II (2006-10)  

• Phase I (2000-05)  

This section details the strategic objectives and operating principles for the current phase (2016-2020), the future phase (2021-2025) as well as providing an overview of previous strategies. 

You can also learn more about our vaccine investment strategy, which we use to determine which vaccines are made available to countries through our vaccine support programmes. A new strategy is developed every five years, when we take stock of available and expected vaccines and set new priorities through in-depth analysis and widespread consultations. The latest vaccine investment strategy was developed in 2013 and covers the period 2014-2018.